Fasenra Approved in China for Severe Eosinophilic Asthma
China's National Medical Products Association (NMPA) has approved AstraZeneca’s Fasenra (benralizumab) for…
Imfinzi Approved in the US for Resectable Lung Cancer Treatment
The US has approved AstraZeneca's Imfinzi (durvalumab) combined with chemotherapy to treat…
BenevolentAI, AstraZeneca Collaboration Hits New Milestone
London- June 2024: BenevolentAI announces that AstraZeneca has added a novel target…
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030
May 2024- AstraZeneca revealed its bold ambition to deliver $80 billion in…
AstraZeneca plans $1.5 billion manufacturing facility in Singapore
20 May 2024- AstraZeneca intends to build a $1.5 billion manufacturing facility…
AstraZeneca Reveals New Research on Respiratory & Immune Diseases
May 2024- AstraZeneca will showcase new clinical and real-world data across its…
AstraZeneca increases 2024 dividend by 7%
April 11 2024- AstraZeneca announced that the Board intends to increase the…
AstraZeneca to acquire Fusion Pharmaceuticals
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc.,…
Beyfortus Approved in China: Could This Be the Answer to Preventing RSV in Infants?
China- January 2024- China has approved Beyfortus (nirsevimab), a newly developed long-acting…
Abu Dhabi Public Health Centre Collaborates with AstraZeneca and SEHA to Decarbonize Healthcare Ecosystem
Abu Dhabi, UAE – December 2023 – At COP28, the Abu Dhabi…
